Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy.
Dimethylfumarate induces apoptosis in human mast cells.
FOCIS: Advanced Course in Basic & Clinical Immunology
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
Neurovascular and Immuno-Imaging Symposium
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
8th Annual Symposium on Glial-Neuronal Interactions
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: A meta-analysis.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Three-Month Test-Retest Reliability of Center of Pressure Motion During Standing Balance in Individuals with Multiple Sclerosis.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Qiagen Webinar: Molecular Mechanisms of Neurodegeneration
ForuMS: A Virtual Journal Club for MS Clinicians
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Reassessing the risk of natalizumab-associated PML.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Episode 11 with Dr. Jack Antel on remyelination and on bedside-to-bench research
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »